BML-111

BML-111, a lipoxin A4 analog, is a lipoxin A4 receptor agonist. BML-111 represses the activity of angiotensin converting enzyme (ACE) and increases the activity of angiotensinconverting enzyme 2 (ACE2). BML-111 has antiangiogenic, antitumor and anti-inflammatory properties.


Cat. No.: EX-A7622	Purity: >98%

	Chemical structure of BML-111

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
25mg	850	In-stock
50mg	1285	In-stock
100mg	1885	Inquire
200mg	2885	Inquire

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


Synonyms	BML 111
CAS No.	78606-80-1
Purity	>98%
Formula	C8H16O5
Mol Weight	192.2096
Color	Colorless to light yellow
State	solid-liquid mixture
Solubility	DMSO : 200 mg/mL
Shelf Life	>2 years if stored properly
Storage	Pure form -20℃ 3 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Ying Chen, et al. Lipoxin A4 and Its Analogue Suppress the Tumor Growth of Transplanted H22 in Mice: The Role of Antiangiogenesis. Mol Cancer Ther. 2010 Aug;9(8):2164-74. [2]. Qiong-Feng Chen, et al. BML-111, a Lipoxin Receptor Agonist, Protects Against Acute Injury via Regulating the Renin Angiotensin-Aldosterone System. Prostaglandins Other Lipid Mediat. 2019 Feb;140:9-17.
CoA	CoA of BML-111


		Search